Buy MDAI by Jul 11, 2026.

MDAI (SpectralAI) has just officially announced that it's flagship product has received FDA approval. There was a massive surge in volume but the stock remained hovering around the $2.4-$2.5 mark, an 8% drop from the previous close of $2.6. This seems largely due to an institution looking to find exit liquidity for it's earlier capital raising agreements with SpectralAI. Once buyers buy through the institutional selling position, the stock seems primed for a massive jump. Most selling is being heavily …